Xenobiotic–urea conjugates; chemical or biological?

References

• Abel JL, Rowntree LG, Turner BB. (1914). On the removal of diffusible substances from the circulating blood of living animals by dialysis. II. Some constituents of the blood. J Pharmacol Exp Ther 5:611–23
   Google Scholar
• Alván G, Jönsson M, Sundwall A, Vessman J. (1977). First-pass conjugation and enterohepatic recycling of oxazepam in dogs; intravenous tolerance of oxazepam in propylene glycol. Acta Pharmacol Toxicol 40:16–27
   PubMedGoogle Scholar
• Asami S, Saito K, Maeda A, Tateishi N. (2010). Anti-fatigue agents and oral compositions containing andrographolide as active ingredient. US Patent Appl. 20100144866 A1. (Assignee: Suntory Holdings Ltd, Osaka-sh, Japan), 10 June 2010, 4 p
   Google Scholar
• Backer HJ. (1943). Boerhaave’s Ontdekking van het Ureum (Boerhaave’s discovery of urea). Ned T Geneesk 87:1274–8
   Google Scholar
• Baumann E, Hoppe-Seyler F. (1874). Ueber Methyl-hydantoinsäure. Ber Deut Chem Ges 7:34–8
   Google Scholar
• Baumann E, von Mering J. (1875). Ueber das Verhalten des Sarkosins im Organismus. Ber Deut Chem Ges 8:584–9
   Google Scholar
• Bell SC, Childress SJ. (1962). A rearrangement of 5-aryl-1,3-dihydro-2H-1,4-benzodiazepine-2-one 4-oxides. J Org Chem 27:1691–5
   Web of Science ®Google Scholar
• Bernardi L, Coda S. (1975). 4H-3-Carbamoylmethyl-1,3-benzoxazin-2-one. South African Patent ZA7402435. (Assignee: Societa Farmaceutici Italia S.p.A., Italy), 30 April 1975. 7 p. Also, Jpn Kokai JP 50135088, 25 October 1975, 2 p
   Google Scholar
• Bernardi L, Coda S, Pegrassi L, Suchowsky GK. (1968). Pharmacological properties of some derivatives of 1,3-benzoxazine. Experientia 24:774–5
   PubMedGoogle Scholar
• Bernardi L, Coda S, Pegrassi L, Suckowsky GK. (1969). Carboxamidoalkyl-1,3-benzoxazines. US Patent 3,427,313. (Assignee: Societá Farmaceutici Italia, Milan, Italy), 11 February 1969, 3 p. Also, GB Patent 1115759, 29 May 1968, 6 p
   Google Scholar
• Bernardi L, Coda S, Nicolella V, et al. (1979). Radioisotopic and synthetic studies related to caroxazone metabolism in man. Arzniem-Forsch 29:1412–16
   PubMedGoogle Scholar
• Bertagni P, Bianchi R, Marcucci F, et al. (1978). The enterohepatic circulation of oxazepam-O-glucuronide in guinea-pigs. J Pharm Pharmacol 30:185–6
   PubMedGoogle Scholar
• Bhatnagar VM. (1963). Clathrate compounds of urea and thiourea. J Sci Ind Res, Sect B, Phys Sci 22:44–9
   Google Scholar
• Bhatnagar VM. (1967). Clathrates of urea and thiourea. Zhurn Strukt Khim 8:568–6
   Google Scholar
• Blaut M, Braune A, Wunderlich S, et al. (2006). Mutagenicity of arbutin in mammalian cells after activation by human intestinal bacteria. Food Chem Toxicol 44:1940–7
   PubMed Web of Science ®Google Scholar
• Blendermann H. (1882). Beiträge zur Kenntniss der Bildung und Zersetzung des Tyrosins im Organismus. Zeit Physiol Chem 6:234–62
   Google Scholar
• Blessing RH. (1983). Interdependence of carbon-nitrogen and carbon-oxygen bond lengths in urea structures and in ureido ring structures. J Am Chem Soc 109:2776–83
   Google Scholar
• Bodansky M. (1927). Introduction to physiological chemistry. London: Chapman and Hall Ltd, 277–82
   Google Scholar
• Boerhaave H. (1727). A new method of chemistry. Part III. The practice of chemistry. Process 87. Urine – will yield an essential salt. (translated by P. Shaw, E. Chambers). London: J. Osborn and T. Longman, 193
   Google Scholar
• Boerhaave H. (1732). Elementa chemiae. Leipzig (Lipsiae): apud Casper Fritsch, 2:276–77
   Google Scholar
• Boerhaave H. (1741). A new method of chemistry. Part II. Process 98 (mislabelled as CXVIII -118) (translated from the Latin by P. Shaw). Vol. 2. London: Longman, 198–9
   Google Scholar
• Boyd WJ. (1933). The isolation of amino-acids in the form of the corresponding carbamido-acids and hydantoins. 1. The derivatives of the mono-amino-monocarboxylic acids. Biochem J 27:1838–48
   PubMedGoogle Scholar
• Brousseau ME, Schaefer EJ, Wolfe EJ, et al. (2004). Effects of an inhibitor of cholesterol ester transfer protein on HDL cholesterol. New Engl J Med 350:1505–15
   PubMed Web of Science ®Google Scholar
• Brown BR. (1994). The organic chemistry of aliphatic nitrogen compounds. Oxford: Clarendon Press, 406–15
   Google Scholar
• Caccia C, Carfagna N, Fariello R. (1992). Caroxazone as antiparkinson MAO reversible inhibitor. PCT Int Patent Appl WO 9202224. (Assignee: Farmitalia Carlo Erba S.r.l., Italy), 20 February 1992, 13 p. Also, Patent Applications, EP0495959 A1, 29 July 1992; CA2067170 A1, 11 February 1992
   Google Scholar
• Chang SW, Reddy V, Pereira T, et al. (2007). The pharmacokinetics and disposition of MK-0524, a prostaglandin D2 receptor 1 antagonist, in rats, dogs and monkeys. Xenobiotica 37:514–33
   PubMed Web of Science ®Google Scholar
• Cheng K, Wu T-J, Wu KK, et al. (2006). Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans. PNAS 103:6682–7
   PubMed Web of Science ®Google Scholar
• Clark RW, Sutfin TA, Ruggeri RB, et al. (2004). Raising high-density lipoprotein in humans through inhibition of cholesterol ester transfer protein: an initial multidose study of torcetrapib. Arterioscler Thromb Vasc Biol 24:490–7
   PubMed Web of Science ®Google Scholar
• Cruickshank W. (1798). Experiments on urine and sugar. Section I. Experiments on urine. In: Rollo J, ed. Cases of the diabetes mellitus, 2nd edn. London: Gillet T, (for Dilly C), 438–51
   Google Scholar
• Cui L, Chan W, Qiu F, et al. (2008). Identification of four urea adducts of andrographolide in humans. Drug Metab Lett 2:261–8
   PubMedGoogle Scholar
• Cui L, Qiu F, Wang N, Xao X. (2004). Four new andrographolide metabolites in human urine. Chem Pharm Bull 52:772–5
   PubMed Web of Science ®Google Scholar
• Cui L, Qiu F, Xao X. (2005). Isolation and identification of seven glucuronide conjugates of andrographolide in human urine. Drug Metab Dispos 33:555–62
   PubMed Web of Science ®Google Scholar
• Dakin HD. (1909). The mode of oxidation in the animal organism of phenyl derivatives of fatty acids. Part VI. The fate of phenylalanine, phenyl-β-alanine, phenylserine, phenylglyceric acids and phenylacetaldehyde. J Biol Chem 6:235–43
   Google Scholar
• Dakin HD. (1910a). The mode of oxidation of phenyl derivatives of fatty acids. A correction. J Biol Chem 8:35–9
   Google Scholar
• Dakin HD. (1910b). The fate of inactive tyrosine in the animal body together with some observations upon the detection of tyrosine and its derivatives in the urine. The synthesis and probably mode of formation of Blendermann’s para-hydroxybenzylhydantoin. J Biol Chem 8:25–33
   Google Scholar
• Dakin HD. (1922). Oxidations and reductions in the animal body, 2nd edn. London: Green and Co, 64
   Google Scholar
• Dalvie DK. (2008). Metabolism, excretion and disposition of torcetrapib in healthy volunteers. 15th North American regional ISSX Meeting, San Diego, CA: 12–16 October 2008. Drug Metab Rev 40:1–308 (Abstract 262)
   Google Scholar
• Dalvie D, Chen W, Zhang C, et al. (2008). Pharmacokinetics, metabolism and excretion of torcetrapib, a cholesteryl ester transfer protein inhibitor, in human. Drug Metab Dispos 36:2185–98
   PubMed Web of Science ®Google Scholar
• Damon DB, Dugger RW, Scott RW. (2003). Methods for preparing CETP inhibitors. US Patent 6,600,045 (Assignee: Pfizer Inc. New York NY), 29 July 2003, 4 p
   Google Scholar
• Davies M, Hopkins L. (1957). The bonding in urea and in the urea ion. Trans Faraday Soc 53:1563–9
   Google Scholar
• Davis FA, Sheppard AC. (1989). Applications of oxaziridines in organic synthesis. Tetrahedron 45:5703–42
   Web of Science ®Google Scholar
• Davy J. (1811). An account of a new gas, with a reply to Mr Murray’s last observations on oxymuriatic gas. J Nat Phil (Nicholson’s J) 30:28–33
   Google Scholar
• Davy J. (1812). On a gaseous compound of carbonic oxide and chlorine. Phil Trans R Soc Lond 102:144–51. Also, J Nat Phil (Nicholson’s J) (1812) 32:241–7
   Google Scholar
• Dean BJ, Chang S, Elipe MVS, et al. (2007). Metabolism of MK-0524, a prostaglandin D2 receptor 1 antagonist, in microsomes and hepatocytes from preclinical species and humans. Drug Metab Dispos 35:283–92
   PubMed Web of Science ®Google Scholar
• Dorland L, van Rhee AM, van Pelt J, et al. (1988). Mannosy-β(1-4)-N-acetylglucosaminyl-β(1-N)-urea, a compound isolated from the urine of patients with β-mannosidosis. Glycoconjugate J 5:215–19
   Google Scholar
• Edwards K, Jackson H, Jones AR. (1970). Studies with alkylating esters – III: the metabolism and fate of methylene dimethanesulphonate. Biochem Pharmacol 19:1791–5
   PubMed Web of Science ®Google Scholar
• Emmons WD. (1956). The synthesis of oxaziranes. J Am Chem Soc 78:6208–9
   Web of Science ®Google Scholar
• Folin O. (1905). Approximately complete analyses of thirty ‘normal’ urines. Am J Physiol 13:45–65
   Google Scholar
• Fourcroy AF, Vauquelin LN. (1799). Extrait d’un premier mémoire des cit. Fourcroy et Vauquelin, pour server ä l’histoire naturelle chimique et médicale de l’urine humaine, contenant quelque faits nouveaux sur son analyse et sur son altération spontanée. Ann Chim 31:48–71
   Google Scholar
• Fourcroy AF, Vauquelin LN. (1800). Deuxieme mémoire: pour server a l’histoire naturelle, chimique et médicale de l’urine humaine, dans lequel on s’occupe spécialement des proprieties de la matière particulière qui le charactérise. Ann Chim 32:80–112, 113–62
   Google Scholar
• Frias MA, Winik B, Franzoni MB, et al. (2008). Lysophosphatidylcholine-arbutin complexes form bilayer-like structures. Biochim Biophys Acta 1778:1259–66
   PubMedGoogle Scholar
• Friedmann E. (1931). Verhalten von dl-α-Naphthylalanin im tierischen Organismus. Biochem Zeit 242:266–81
   Google Scholar
• Frost AA, Pearson RG. (1961). Kinetics and mechanisms, study of homogenous chemical reactions. 2nd edn. New York: Wiley, 307
   Google Scholar
• Gornall AG, Hunter A. (1940). The behaviour of some uramido-acids in the nitrous acid method for the determination of amino-nitrogen. Biochem J 34:192–7
   PubMedGoogle Scholar
• Gorter K. (1911). Sur le principe amer de l’Andrographis paniculata N. Rec Trav Chim 30:151–60
   Google Scholar
• Gorter K. (1914). Sur l’andrographolide. Rec Trav Chim 33:239–43
   Google Scholar
• Griffin RJ, Burka LT. (1993). Metabolism and elimination of oxazepam in B6C3F1 and Swiss-Webster mice. Drug Metab Dispos 21:918–26
   PubMed Web of Science ®Google Scholar
• He X, Li J, Gao H, Qiu F, et al. (2003a). Six new andrographolide metabolites in rats. Chem Pharm Bull 51:586–9
   PubMed Web of Science ®Google Scholar
• He XJ, Li JK, Gao H, et al. (2003b). Four new andrographolide metabolites in rats. Tetrahedron 59:6603–7
   Web of Science ®Google Scholar
• He X, Li J, Gao H, et al. (2003c). Identification of a rare sulfonic acid metabolite of andrographolide in rats. Drug Metab Dispos 31:983–5
   PubMed Web of Science ®Google Scholar
• Hemminki K. (1984). Urinary excretion products of formaldehyde in the rat. Chem Biol Interact 48:243–8
   PubMedGoogle Scholar
• Hildebrandt H. (1903). Auf das Verhalten der halogen substituierten Toluolen und Aminobenzoesäuren im Organismus. Beitr Chem Physiol Pathol 3:365–72
   Google Scholar
• Hoppe-Seyler FA. (1933). Lysine excretion in the urine in cystinuria. Hoppe-Seyler’s Z Physiol Chem 214:267–70
   Google Scholar
• Horner L, Jürgens E. (1957). Notiz Über Darstellung und Eigenschaften Einiger isonitrone (Oxazirane). Chem Ber 90:2184–9
   Google Scholar
• Jaffe M. (1902). Antipyrylharnstoff, ein Stoffwechselderivat des Pyramidons. Ber Deut Chem Ges 35:2891–95
   Google Scholar
• Jahodář L, Leifertova I, Lisa M. (1985). Elimination of arbutin from the organism. Folia Pharmaceutica (Prague) 8:7–17
   Google Scholar
• Jencks WP, Regenstein J. (2010). Ionization constants of acids and bases. In: Lundblad RL, MacDonald FM, eds. Handbook of biochemistry and molecular medicine. Cleveland: CRC Press, 595–635
   Google Scholar
• Karanam B, Madeira M, Bradley S, et al. (2007). Absorption, metabolism, and excretion of [14C]MK-0524, a prostaglandin D2 receptor antagonist, in humans. Drug Metab Dispos 35:1196–202
   PubMed Web of Science ®Google Scholar
• Kiep L, Maderner S, Seifert K. (2002). Metabolism of metamizol in early stages of the incubated hen’s egg. Pharmazie 57:829–33
   PubMed Web of Science ®Google Scholar
• Knowles JA, Ruelius HW. (1972). Absorption and excretion of 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one (oxazepam) in humans. Determination of the drug by gas-liquid chromatography with electron capture detection. Arzneim Forsch 22:687–92
   PubMed Web of Science ®Google Scholar
• Krebs HA, Henseleit K. (1932). Studies on urea formation in the animal organism. Hoppe-Seyler’s Z Physiol Chem 210:33–66
   Google Scholar
• Lamoureux GL. (1989). Plant metabolism of herbicides. In: Kato R, Estabrook RW, Cayen MN, eds. Xenobiotic metabolism and disposition. Proceedings of the 2nd International ISSX meeting, Kobe 1988. London: Taylor and Francis, 266–74
   Google Scholar
• Lehr S, Glässgen WE, Sandermann H, et al. (1996). Metabolism of isoproturon in soils originating from different agricultural management systems and in cultures of isolated soil bacteria. Int J Environ Anal Chem 65:231–43
   Web of Science ®Google Scholar
• Lewis DE. (2012). Early Russian organic chemists and their legacy. Berlin: Springer-Verlag, 21
   Google Scholar
• Lin CC, Kim HK, Marco A, et al. (1986). Pharmacokinetics and metabolism of [14C]-rosaramicin in dogs. Antimicrob Agents Chemother 29:753–6
   PubMedGoogle Scholar
• Lin C, Puar MS, Schuessler D, et al. (1984a). Isolation and identification of a metabolite of rosaramicin in human urine. Drug Metab Dispos 12:51–6
   PubMedGoogle Scholar
• Lin CC, Chung M, Gural R, et al. (1984b). Pharmacokinetics and metabolism of rosaramicin in humans. Antimicrob Agents Chemother 26:522–6
   PubMed Web of Science ®Google Scholar
• Lindeboom GA. (1959). Bibliographia boerhaaviana. Leiden: EJ Brill, 81
   Google Scholar
• Lindeboom GA. (1968). Herman Boerhaave, the man and his work. London: Methuen, 333–4
   Google Scholar
• Lippich F. (1906). Ueber Isobutyl-hydantoinsäure und über eine Reaction zum Nachweis kleiner mengen von Leucin. Ber Deut Chem Ges 39:2953–6
   Google Scholar
• Lippich F. (1908). Uber Uramidosauren. Ber Deut Chem Ges 41:2953–83
   Google Scholar
• Mashford PM, Jones AR. (1982). Formaldehyde metabolism by the rat: a re-appraisal. Xenobiotica 12:119–24
   PubMed Web of Science ®Google Scholar
• Mateer JG, Marshall EK Jr (1916). The urease content of certain beans, with special reference to the jack bean. J Biol Chem 25:297–305
   Google Scholar
• Menozzi M, Arcamone F. (1977). Interazione del brofoxine psicofarmaci e caroxazone con le protein plasmatiche. Conv Ital Sci Macromol [Atti] 3rd. Genoa, Italy, Copy-Lito: Instituto Ricerca Nerviano Farmitalia, Milan Italy, 121–3
   Google Scholar
• Mitsuba K, Ichihara K. (1927). Über das Schicksal der Anthranilsäure im Tierkörper. Z Physiol Chem 164:244–54
   Google Scholar
• Moretti A, Caccia C, Carpentieri M, Carfagna N. (1984). Experimental studies with caroxazone. Lack of effects on drug metabolising enzymes. Monoamine Oxidase Diseases (Proc. Conf.). London: Academic Press, 537–46
   Google Scholar
• Morton ID, Hoggarth E. (1952). Carbonic acid and its derivatives. In: Rodd EH, ed. Chemistry of carbon compounds. Vol. 1B. London: Elsevier Publishing Co, 905–14
   Google Scholar
• Muecke W. (1983). Separation and purification of pesticide metabolites. In: Hutson DH, Roberts TR, eds. Vol 3. Progress in pesticide biochemistry and toxicology. Chichester: Wiley, 279–366
   Google Scholar
• Natanson M. (1856a). Sur deux nouveaux modes de formation de l’urée. Ann Chim Phys 48:109–11
   Google Scholar
• Natanson M. (1856b). Ueber zwei neue kunstliche Bildungsweisen des Harnstoffs. Justus Liebigs Ann Chem 98:287–91
   Google Scholar
• Neely WB. (1964). The metabolic fate of formaldehyde-14-C intraperitoneally administered to the rat. Biochem Pharmacol 13:1137–42
   PubMed Web of Science ®Google Scholar
• Neild GH. (1996). William Cruickshank (FRS – 1802): clinical chemist. Nephrol Dial Transplant 11:1885–9
   PubMedGoogle Scholar
• Nicoll-Griffith DA, Seto C, Aubin Y, et al. (2007). In vitro biotransformations of the prostaglandin D2 (DP) antagonist MK-0524 and synthesis of metabolites. Bioorg Med Chem 17:301–4
   Google Scholar
• Orozco JLH, Aquilera RAB. (2011). Composition of labdane diterpenes extracted from andrographis paniculata, useful for the treatment of autoimmune diseases, and Alzheimer disease by activation of PPR-gamma receptors. US Patent 8,084,495. (Assignee: Herbal Powers Corporation, Bradenton, FL) 27 December 2011. Also, PCT Appl. WO 2005074953, 18 August 2005
   Google Scholar
• Pagel W. (1982). Jean Baptiste van Helmont: reformer of science and medicine. Cambridge: Cambridge University Press
   Google Scholar
• Panossian A, Hovhannisyan A, Mamikonyan G, et al. (2000). Pharmacokinetic and oral bioavailability of andrographolide from Andrographis paniculata fixed combination Kan Jang in rats and human. Phytomed 7:351–64
   PubMed Web of Science ®Google Scholar
• Pelzer H, Maass D. (1969). Pharmacokinetik und metabolismus von 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-on und dessen hemisuccinat beim menschen. Arzneim Forsch 19:1652–6
   PubMed Web of Science ®Google Scholar
• Perrin-Ganier C, Schiavan F, Morel JL, Schiavan M. (2001). Effect of sludge-amendment or nutrient addition on the biodegradation of the herbicide isoproturon in soil. Chemosphere 44:887–92
   PubMed Web of Science ®Google Scholar
• Pluta T, Sadlej AJ. (2001). Electric properties of urea and thiourea. J Chem Phys 114:136–46
   Web of Science ®Google Scholar
• Prakash C, Chen W, Rossulek M, et al. (2008). Metabolism, pharmacokinetics, and excretion of a cholesterol ester transfer protein inhibitor, torcetrapib, in rats, monkeys and mice: characterization of unusual and novel metabolites by high-resolution liquid-chromatography-tandem mass spectrometry and 1H nuclear magnetic resonance. Drug Metab Dispos 36:2064–79
   PubMed Web of Science ®Google Scholar
• Prout W. (1817). Observations on the nature of some of the proximate principles of the urine, with a few remarks upon the means of preventing those diseases, connected with a morbid state of that fluid. Med Chir Trans 8:526–49
   Google Scholar
• Qui F, Cui L, Chen L, et al. (2012). Two novel creatinine adducts of andrographolide in human urine. Xenobiotica 42:911–16
   PubMedGoogle Scholar
• Quintus J, Kovar KA, Link, P, Hamacher H. (2005). Urinary excretion of arbutin metabolites after oral administration of bearberry leaf extracts. Planta Med 71:147–52
   PubMedGoogle Scholar
• Ratner S, Clarke, HT. (1937). The action of formaldehyde upon cysteine. J Amer Chem Soc 59:200–6
   Google Scholar
• Redemann CE, Riesenfeld FC, La Viola FS. (1958). Formation of biuret from urea. Ind Eng Chem 50:633–6
   Google Scholar
• Regnault V. (1838). Action du gaz ammoniac sec sur le gaz chloro-carbonique. Ann Chim Phys 69:180–3
   Google Scholar
• Rhode A. (1917). A method for the identification of phenylalanineuramino acid in the presence of urea and amino acid. Proc Am Soc Biol Chem, J Biol Chem 29:xxvii–iii
   Google Scholar
• Rhode A. (1918). A method for the identification of certain uramino-acids in the presence of amino acids and of urea. J Biol Chem 36:467–74
   Google Scholar
• Roberts TR, Hutson DH. (1998). Metabolic pathways of agrochemicals: herbicides and plant growth regulators. Part 1. London: Royal Society of Chemistry, 705–2
   Google Scholar
• Rouelle HM. (1773). Observations sur l’urine humaine, et sur celle de vache et de cheval, comparées ensemble. J Méd Chir Pharm 40:451–68
   Google Scholar
• Ruelius HW, Tio CO, Knowles JA, et al. (1979). Diastereoisomeric glucuronides of oxazepam. Isolation and stereoselective enzyme hydrolysis. Drug Metab Dispos 7:40–3
   PubMed Web of Science ®Google Scholar
• Sakai A, Yasuda N, Fujiwara T, et al. (1987). Studies of 16-membered macrolide-urea adducts. Drug Metab Pharmacokinet 6:625–36
   Google Scholar
• Salkowski E. (1872). Ueber die Bildung der Schwefelsäure und des Harnstoffs und das Verhalten des Taurins im Thierkörper. Ber Deut Chem Ges 5:637–9
   Google Scholar
• Salkowski E. (1873a). Ueber die Taurocarbaminsäure. Ber Deut Chem Ges 6:744–6
   Google Scholar
• Salkowski E. (1873b). Ueber die Entstehung der Schwefelsaure und das Verhalten des Taurins im thierischen Organismus. Virchow’s Arch Pathol Anat Physiol 58:460–508
   Google Scholar
• Salkowski E. (1877). Ueber den Vorgang der Harnstoffbildung im Thierkörper und den Einfluss der Ammoniaksalze auf denselben. Hoppe-Seyler’s Z Physiol Chem 1:1–24
   Google Scholar
• Salkowski E. (1880). Weitere Beiträge zur Theorie der Harnstoffbildung: das Verhalten des Glycocoll etc. im Organismus (Zweiter Theil). Zeit Physiol Chem 4:100–32
   Google Scholar
• Salkowski E. (1882). Weitere Beiträge zur Kenntniss der Harnstoffbildung: das Verhalten der Amidobenzoësäure im Thierkörper. Zeit Physiol Chem 7:93–113
   Google Scholar
• Scheringer C. (1980). Bond-length corrections for external and internal vibrations in urea. Acta Cryst A36:814–18
   Google Scholar
• Schiffer J. (1881). Ueber das Schiksal des Sarkosins im menschlichen organismus. Zeit Physiol Chem 5:257–66
   Google Scholar
• Schiller J. (1967). Wöhler, l’urée et la vitalisme. Sudhoffs Archiv 51:229–43
   PubMedGoogle Scholar
• Schindler G, Patzak U, Brinkhaus B, et al. (2002). Urinary excretion and metabolism of arbutin after oral administration of Arctostaphylos uvae ursi extract as film-coated tablets and aqueous solution in healthy humans. J Clin Pharmacol 42:920–7
   PubMed Web of Science ®Google Scholar
• Schmidt CLA, Allen EG. (1920). Further studies on the elimination of taurine administerd to man. J Biol Chem 42:55–8
   Google Scholar
• Schmiedeberg O. (1878). Ueber das Verhaltniss des Ammoniaks und der primären Monaminbasen zur Harmstoff-bildung imThierkörper. Arch Exp Pathol Pharmakol 8:1–14
   Google Scholar
• Schmitz E, Fechner-Simon H, Schramm S. (1969). Triazane. 1. Bildung und Zerfall der N-N-N-Gruppierung. Liebigs Ann Chem 725:1–10
   Google Scholar
• Schmitz E, Ohme R, Schramm S. (1964). Isomere Oxime mit Dreiringstruktur. Chem Ber 97:2521–6
   Google Scholar
• Schultzen O. (1872). Die Entstehung des Harnstoffs im Thierkörper. Ber Deut Chem Ges 5:578–81
   Google Scholar
• Sherwin CP. (1922). The fate of foreign organic compounds in the animal body. Physiol Rev 2:238–76
   Google Scholar
• Shorter J. (1978). The conversion of ammonium cyanate into urea – a saga in reaction mechanisms. Chem Soc Rev 7:1–14
   Web of Science ®Google Scholar
• Sisenwine SF, Tio CO. (1986). The metabolic disposition of oxazepam in rats. Drug Metab Dispos 14:41–5
   PubMed Web of Science ®Google Scholar
• Sisenwine SF, Tio CO, Liu AL, Politowska JF. (1987). The metabolic fate of oxazepam in mice. Drug Metab Dispos 15:579–80
   PubMed Web of Science ®Google Scholar
• Sisenwine SF, Tio CO, Shrader SR, Ruelius HW. (1972). The biotransformation of oxazepam (7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one) in man, miniature swine and rat. Arzneim Forsch 22:682–7
   PubMed Web of Science ®Google Scholar
• Sisenwine SF, Tio CO, Hadley FV, et al. (1982). Species-related differences in the stereoselective glucuronidation of oxazepam. Drug Metab Dispos 10:605–8
   PubMed Web of Science ®Google Scholar
• Skurski P, Simons J. (2001). An excess electron bound to urea. 1. Canonical and zwitterionic tautomers. J Chem Phys 115:8373–80
   Web of Science ®Google Scholar
• Sørensen SB, Bending GD, Jacobsen CS, et al. (2003). Microbial degradation of isoproturon and related phenylurea herbicides in and below agricultural fields. FEMS Microbiol Ecol 45:1–11
   PubMed Web of Science ®Google Scholar
• Sturino CF, O’Neill G, Lachance N, et al. (2007). Discovery of a potent and selective prostaglandin D2 receptor antagonist [(3R)-4-(4-chlorobenzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta [b]indol-3-yl]-acetic acid (MK-0524). J Med Chem 50:794–806
   PubMed Web of Science ®Google Scholar
• Thierfelder H, Sherwin CP. (1914). Phenylacetyl-glutamin, ein Stoffwechsel-Produkt des menschlichen Körpers nach Eingabe von Phenyl-essigsäure. Ber deut Chem Ges 47:2630–4
   Google Scholar
• Thierfelder H, Sherwin CP. (1915). Phenylacetylglutamin und seine Bildung im menschlichen Körper nach Eingabe von Phenylessigsäure. Hoppe-Seyler’s Zeit Physiol Chem 94:1–9
   Google Scholar
• Thongchai W, Liawruangrath B, Liawruangrath S. (2009). Arbutin determination in medicinal plants and creams. Int J Cosmet Sci 31:87–96
   PubMedGoogle Scholar
• van Helmont JB. (1644). Opuscula medica inaudita, I. De Lithiasi, II. De Febribus, III. De Humoribus Galeni, IV. De Peste. Cologne (Coloniae Agrippinae): apud Jodocum Kalcoven. Caput II, No 30–3
   Google Scholar
• Vaughan P, Donohue P. (1952). The structure of urea. Interatomic distances and resonance in urea and related compounds. Acta Cryst 5:530–5
   Google Scholar
• Vauquelin M. (1818). Sur le cyanogène et sur l’acide Hydrocyanique. Ann Chim Phys 9:113–46
   Google Scholar
• Ville J. (1892). Transformation, dans l’economie, de l’acide sulfanilique en acide sulfanilocarbamique. C R Hebd Séanc Acad Sci (Paris) 114:228–31
   Google Scholar
• Vogt A, Kassner U, Hostalek U, Steinhagen-Thiessen E. (2006). On behalf of the Nautilus Study Group, 2006. Evaluation of safety and tolerability of prolonged-release nicotinic acid in a usual care setting. Curr Med Res Opin 22:417–25
   PubMed Web of Science ®Google Scholar
• Volz M, Kellner HM. (1980). Kinetics and metabolism of pyrazolones (propyphenazone, aminopyrine and dipyrone). Br J Clin Pharmacol 10:299S–308S
   Web of Science ®Google Scholar
• Wada M. (1933). Eine neue Methode zur Darstellung von Aminen aus Aminosäuren. Biochem Zeit 260:47–51
   Google Scholar
• Wagman GH, Waitz JA, Marquez J, et al. (1972). A new Micromonospora-produced macrolide antibiotic, rosamicin. J Antibiotics 25:641–6
   PubMedGoogle Scholar
• Waitz JA, Drube CG, Moss EL Jr, Weinstein MJ. (1972). Biological studies with rosamicin, a new Micromonospora-produced macrolide antibiotic. J Antibiotics 25:647–52
   PubMedGoogle Scholar
• Walkenstein SS, Wiser R, Gudmundsen CH, et al. (1964). Absorption, metabolism, and excretion of oxazepam and its succinate half-ester. J Pharmaceut Sci 53:1181–6
   PubMed Web of Science ®Google Scholar
• Weiland W. (1912). Beltrag zur Lehre von der Uraminosäurebildung. Biochem Z 38:385–93
   Google Scholar
• Werner EA. (1914). LXXXVIII. The constitution of carbamides. Part 1. The preparation of isocarbamides by the action of methyl sulphate on carbamides. J Chem Soc Trans 105:923–32
   Google Scholar
• Werner EA. (1923). The chemistry of urea. London: Longmans Green and Co, 1–209
   Google Scholar
• Wieruszeski J-M, Montreuil J, Strecker G, Farriaux J-P. (1985). Glycoconjugates. In: Davidson EA, Williams JC, Di Ferrante NM, eds. Proc. Eighth International Symposium, Houston, Texas, 8–13 September Vol. 2. New York: Praeger, 125
   Google Scholar
• WHO. (1996). Isoproturon in drinking water. In: guidelines for drinking water quality; health criteria and other supporting information. 2nd edn. Vol. 2. Geneva; World Health Organisation. Also, background document for development of WHO ‘Guidelines for drinking-water quality’ WHO/SDE/WSH/03.04/37 (2003)
   Google Scholar
• Williams RT. (1959). Detoxication mechanisms. The metabolism and detoxication of drugs: toxic substances and other organic compounds. 2nd edn. London: Chapman and Hall Ltd, 575
   Google Scholar
• Wöhler F. (1822a). Sur l’acide particulier qui se forme lorsque l’on combine le cyanogène avec les alcalis. Ann Chim Phys 20:353–9
   Google Scholar
• Wöhler F. (1822b). Ueber die eigenthümliche Säure, weiche Cyan (Blaustoff) von Alkalien aufgenommen wird. Ann Phys Chem 71:95–103
   Google Scholar
• Wöhler F. (1825). Ueber Cyan-Verbindungen. Ann Phys Chem 79:177–82
   Google Scholar
• Wöhler F. (1828a). Ueber künstliche Bildung des Harnstoffs. Ann Phys Chem 88:253–6
   Google Scholar
• Wöhler F. (1828b). Sur la formation artificielle de l’urée. Ann Chim Phys 37:330–4
   Google Scholar
• Wouters J, Evrard G, Durant F. (1994). The molecular structure of caroxazone, a reversible monoamine oxidase inhibitor. Acta Cryst C50:1774–7
   Google Scholar
• Zhou B, Zhang D, Wu X. (2013). Biological activities and corresponding SARs of andrographolide and its derivatives. Mini Rev Med Chem 13:298–309
   PubMed Web of Science ®Google Scholar